Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04774913 · ClinicalTrials.gov registry record · NA

Invest-CTO PCI Trial

A NA study of Quality of Life and Angina Pectoris, sponsored by Haukeland University Hospital.

Active
Registry status
NA
Development phase
200
Enrollment target
5
Study locations

NCT04774913: Active NA study of Quality of Life and Angina Pectoris, sponsored by Haukeland University Hospital.

NCT04774913 is a NA study of Quality of Life and Angina Pectoris that is active but no longer recruiting, run by Haukeland University Hospital. The registered enrollment target is 200 participants, below the 451-participant average among 107 other Quality of Life trials with a reported enrollment target (56% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04774913, a NA study of Quality of Life and Angina Pectoris, is active but no longer recruiting, sponsored by Haukeland University Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
5
Study locations

Study Summary

Following unsuccessful CTO crossing a CTO modification procedure is sometimes performed. CTO PCI registries where plaque modification has been performed in some patients, report this to be safe, and associated with higher success rates at subsequent attempts. It has never been investigated whether a planned investment procedure, with an intention that both the initial and staged completion PCI are of shorter duration, could improve safety and efficacy. The investigators hypothesize that 1. A planned investment procedure in the treatment of CTOs will be associated with improved patient safety 2. A planned investment procedure will be associated with improved cumulative procedure success rates 3. A planned two stage procedure will be associated with improved patient experience

Primary Outcome

CTO PCI Procedural success, Complete technical success plus the absence of an in-hospital major adverse cardiovascular event (MACE; death, MI, or clinically driven target vessel revascularization \[TVR\]

Interventions

  • PROCEDURE Chronic total occlusion(CTO) percutaneous coronary intervention (PCI)

Study Locations (5)

Other

  • Bristol Health - Bristol
  • St George´s Hospital - London

New York

  • Columbia University Medical Center/ NewYork Presbyterian Hospital - New York

Bergen

  • Haukeland University Hospital - Bergen

Glasgow

  • Golden Jubilee National Hospital - Glasgow

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-12-08
Est. Completion 2026-10
Phase NA
Haukeland University Hospital

1 total trials

What the registry record for NCT04774913 still lists

NCT04774913 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 451-participant average among 107 other Quality of Life trials with a reported enrollment target (56% lower).

The record links to 4 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Chronic total occlusion(CTO) percutaneous coronary intervention (PCI) is the first listed.

NCT04774913 lists 5 locations in 4 states (Other, New York, Bergen).

Frequently Asked Questions

What is clinical trial NCT04774913 about?

NCT04774913 is a clinical study titled "Invest-CTO PCI Trial". Following unsuccessful CTO crossing a CTO modification procedure is sometimes performed. CTO PCI registries where plaque modification has been performed in some patients, report this to be safe, and associated with higher success rates at subsequent attempts. It has never been investigated whether ...

What is the current status of trial NCT04774913?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-12-08. Estimated completion is 2026-10.

What conditions does trial NCT04774913 study?

This clinical trial studies the following conditions: Quality of Life, Angina Pectoris, Chronic Total Occlusion of Coronary Artery, PROM.

What interventions are being tested in trial NCT04774913?

The interventions under investigation include: Chronic total occlusion(CTO) percutaneous coronary intervention (PCI) (PROCEDURE).

Who is sponsoring clinical trial NCT04774913?

This trial is sponsored by Haukeland University Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04774913 being conducted?

This trial has 5 study locations across New York, Bergen, Glasgow. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04774913's enrollment target sits among peer trials

200 36th of 107 higher than 72 of 107 other Quality of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04774913, the US trial registry maintained by the National Library of Medicine. NCT04774913 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.